Partner Reed Kathrein Investigating Alleged Fraudulent Enrollment Metrics and the Direct Causation Linking Operational Failure to Massive Investor Losses National shareholder rights law firm Hagens Berman is issuing a reminder to investors in Stride, Inc. (NYSE: LRN) that the deadline to move the Court for appointment as lead plaintiff in the pending securities class action […]

Partner Reed Kathrein Scrutinizing Alleged Misstatements on Prostate Cancer Drug TLX591 Progress and Third-Party Manufacturing Deficiencies (Form 483) National shareholder rights law firm Hagens Berman is issuing a reminder to investors in Telix Pharmaceuticals Ltd. (NASDAQ: TLX) that the deadline to move the Court for appointment as lead plaintiff in the pending securities class action

National plaintiffs' law firm Berger Montague PCannounces that a class action lawsuit against Fiserv, Inc. (NASDAQ: FISV) (NYSE: FI) (“Fiserv” or the “Company”) has been filed on behalf of investors who purchased Fiserv shares during the period ofJuly 23, 2025 through October 29, 2025 (the “Class Period”). https://mma.prnewswire.com/media/232479/berger_montague.jpg Investor Deadline: Investors who purchased Fiservsecurities during

Partner Reed Kathrein Urges Investors to Contact Firm Before January 5, 2026 Lead Plaintiff Deadline National investor rights law firm Hagens Berman alerts INSP investors to the pending securities class action lawsuit against Inspire Medical Systems, Inc. (NYSE: INSP). The firm is urging INSP investors who suffered substantial losses to contact its attorneys before the

Robert Trial Named Chief Executive Officer; Founder David Seuss to Continue as Principal Product Strategist. Company Also Announces Expansion of Senior Leadership Team. Northern Light, a leading provider of Competitive and Market Intelligence solutions for enterprises, today announced a planned leadership transition as part of its continued growth following LoneTree Capital's investment in the company.

Partner Reed Kathrein Urges KMX Investors to Contact Firm Before January 2, 2026Lead Plaintiff Deadline National investor rights law firm Hagens Berman reminds investors that the Lead Plaintiff Deadline in the securities class action lawsuit against CarMax, Inc. (NYSE: KMX) — January 2, 2026 – is rapidly approaching. https://mma.prnewswire.com/media/2590203/Hagens_Berman_Sobol_Shapiro_LLP_Logo.jpg The lawsuit alleges that CarMax and

Partner Reed Kathrein Investigating Alleged Assurances of “Normal” Inventory Levels Against Later Revealed Destocking Trends National shareholder rights law firm Hagens Berman is issuing a reminder to investors in James Hardie Industries plc (NYSE: JHX) as the December 23, 2025, lead plaintiff deadline approaches in a pending securities class action against James Hardie and certain

SFNet's 'In the Know' podcastcovers valuation shifts, tariff impacts, industry-specific pressures, and the expanding role of AI in appraisal analytics. Shifting tariffs, plunging consumer confidence and poor performance in once-thriving sectors like transportation and green energy have made timely and accurate appraisals increasingly critical in asset-based lending, advised the chief of Tiger Group's commercial and

A securities class action lawsuit styled Smith v. F5, Inc., et al., No. 2:25-cv-02619 (W.D. Wash.) has been filed, seeking to represent investors in F5 (NASDAQ: FFIV)who purchased or otherwise acquired F5 securities between October 28, 2024 and October 27, 2025. https://mma.prnewswire.com/media/2590203/Hagens_Berman_Sobol_Shapiro_LLP_Logo.jpg The lawsuit comes in the wake of F5's October 15, 2025 report that,

Aqualung Therapeutics, a clinical-stage immunotherapeutics company, announced today that the Food and Drug Administration (FDA) has cleared its Phase 2a study of ALT-100 mAb as an anti-inflammatory and anti-fibrotic therapy in human subjects with Progressive Pulmonary Fibrosis (PPF). This marks the company's second FDA-approved Investigational New Drug application (IND) following its 2022 clearance for acute